Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Medis Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (1457)
ARTG (51)
Cancellation or suspension (26)
Listed medicine compliance report (5)
Prescription medicine registration (2)

Date

2025 (58)
2024 (1215)
2023 (3)
2022 (29)
2021 (106)
2020 (31)
2019 (6)
2018 (3)
2017 (44)
2016 (5)
2015 (17)
2014 (7)
2013 (2)
2012 (7)
2011 (6)
2010 (1)
2009 (1)

Search

Sponsor content

1541 result(s) found, displaying 51 to 60

DESVENLAFAXINE MEDIS desvenlafaxine 100mg modified release tablets bottle Cancelled under Section 30(1)(c) of the Act

27 March 2025

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
FENPATCH 100 fentanyl 100 mcg/hr transdermal patch pouch Cancelled under Section 30(1)(c) of the Act

18 March 2025

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
FENPATCH 12 fentanyl 12 mcg/hr transdermal patch pouch Cancelled under Section 30(1)(c) of the Act

18 March 2025

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
FENPATCH 50 fentanyl 50 mcg/hr transdermal patch pouch Cancelled under Section 30(1)(c) of the Act

18 March 2025

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
FENPATCH 75 fentanyl 75 mcg/hr transdermal patch pouch Cancelled under Section 30(1)(c) of the Act

18 March 2025

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
FENPATCH 25 fentanyl 25 mcg/hr transdermal patch pouch Cancelled under Section 30(1)(c) of the Act

18 March 2025

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
CLOPIDOGREL/ASPIRIN-ZP 75/100 clopidogrel (as hydrogen sulfate) and aspirin 75 mg/100 mg uncoated tablet blister pack Cancelled under Section 30(1)(c) of the Act

15 January 2025

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
CLOPIDOGREL/ASPIRIN-MEDIS 75/100 clopidogrel (as hydrogen sulfate) and aspirin 75 mg/100 mg uncoated tablet blister pack Cancelled under Section 30(1)(c) of the Act

15 January 2025

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
FOSETIC 20/12.5 fosinopril sodium 20 mg and hydrochlorothiazide 12.5 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

10 December 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
TALDOX docetaxel 20mg/0.5mL concentrated injection vial with diluent vial Cancelled under Section 30(1)(c) of the Act

10 December 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd

Pages

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Page 9
Page 10
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.